Thilo Schroeder, Director at Revolution Medicines, Inc. (RVMD), bought 335,223 shares at $18.78 ($6.8M) on 2022-03-17, disclosed to the SEC on 2022-03-21.
Open-market purchase of $6.8M RVMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.78 | 10,120 | $190K | 2.8% |
| 2 | $18.78 | 10,120 | $190K | 2.8% |
| 3 | $19.28 | 5,992 | $116K | 1.7% |
| 4 | $19.28 | 5,992 | $116K | 1.7% |
| 5 | $20.38 | 76,208 | $1.6M | 22.7% |
| 6 | $20.38 | 76,208 |
| $1.6M |
| 22.7% |
| 7 | $20.73 | 74,852 | $1.6M | 22.7% |
| 8 | $20.73 | 74,852 | $1.6M | 22.7% |
| 9 | $21.22 | 879 | $19K | 0.3% |
| Total | $20.40 avg | 335,223 | $6.8M | 100% |
| Filing → |
| RVMD | BUY | 2022-07-26 | $5.0M | — | Filing → |
| RVMD | BUY | 2022-03-29 | $2.1M | — | Filing → |
| RVMD | BUY | 2022-03-24 | $11.0M | — | Filing → |